To provide brief information for HCPs on Nyxoid

Training Card for Patients and Carers

Information on: How to recognise symptoms of an opioid overdose, What to do, How to give Nyxoid and How to recognise acute withdrawal symptoms

Important information on minimising the risks of cardiac arrhythmia and severity of adverse reactions in those with hepatic impairment

Patient Alert Card-The risk of Cardiac Arrhythmia

Important safety information - Guidance on the administration of Nebido

This card is for patients who are prescribed Neratinib, to carry with them and provide to a non-routine treating clinician to inform them of key information about their neratinib treatment

This document forms one part of the Physician/HCP and Patient/Carer Educational Materials for Nerlynx (neratinib). It is provided for patients to complete on a daily basis to assist with the management of any diarrhoea patients may experience.

This Risk Minimisation Guide is one part of the Physician/HCP Educational Materials. The aim of this brochure is to provide HCPs with information on the management of diarrhoea when prescribing Nerlynx (neratinib).

This Risk Minimisation Guide is one part of the Physician/HCP and Patient/Carer Educational Materials for Nerlynx. This brochure provides specific guidance to patients on how to recognise and manage diarrhoea if it occurs whilst taking Nerlynx (neratinib).

The provision of this card to patients is required by the terms of the Marketing Authorisation. Please ensure that you store the card in a safe place, and show it to your healthcare professional at any visits related to the use of your implant. Ensure that you have read and understood this information as it contains important safety information that you need to be aware of following the insertion of Nexplanon.

For hard copies, please contact medical information department at 0800 035 2525 or email [email protected].

For hard copies, please contact medical information department at 0800 035 2525 or email [email protected].

This item is to provide you with important information about the indications, method of administration and safety precautions to be followed while using IV Nicardipine

In June 2015 Aguettant Ltd received marketing approval for a new Noradrenaline product: namely Noradrenaline (base) 0.08 mg/ml solution for infusion (equivalent to Noradrenaline Tartrate 0.16mg/ml) presented in a 50 ml vial. This product differs from existing Noradrenaline products in both strength and presentation. There is a potential risk of medication errors should healthcare professionals not recognise these new features. Please refer to the Direct Healthcare Professional Communication for further details.

This guide is intended for Health Care Professionals to highlight the risks associated with NORMOSANG® 25 mg/ml, concentrate for solution for infusion administration (thrombosis, extravasation and necrosis) and the precautions to take in order to avoid them.

The Nplate (romiplostim) dose calculator is provided to simplify the calculation of the correct dose and guide to the correct reconstitution and administration procedures. This is a formatted material with a pull out section - to request a printed copy of the dose calculator, please contact Amgen Medical Information on +44 (0) 1223 436441

Physicians who express an interest in initiating self-administration of Nplate (romiplostim) for specific patients are provided with a Home Administration Training pack for those patients. The HAT pack includes materials for HCPs on how to select and train patients for self-administration of romiplostim; and for patients, in order to help them with the process of preparation and self-administration of the correct dose of romiplostim. To request a copy of this material, please contact Amgen Medical Information on +44 (0) 1223 436441

Physicians who express an interest in initiating self-administration of Nplate (romiplostim) for specific patients are provided with a Home Administration Training pack for those patients. The HAT pack includes materials for HCPs on how to select and train patients for self-administration of romiplostim; and for patients, in order to help them with the process of preparation and self-administration of the correct dose of romiplostim. This website is not able to support video upload - to request a copy of the DVD, please contact Amgen Medical Information on +44 (0) 1223 436441

Physicians who express an interest in initiating self-administration of Nplate (romiplostim) for specific patients are provided with a Home Administration Training pack for those patients. The HAT pack includes materials for HCPs on how to select and train patients for self-administration of romiplostim; and for patients, in order to help them with the process of preparation and self-administration of the correct dose of romiplostim. To request a copy of this material, please contact Amgen Medical Information on +44 (0) 1223 436441

Physicians who express an interest in initiating self-administration of Nplate (romiplostim) for specific patients are provided with a Home Administration Training pack for those patients. The HAT pack includes materials for HCPs on how to select and train patients for self-administration of romiplostim; and for patients, in order to help them with the process of preparation and self-administration of the correct dose of romiplostim. To request a copy of this material, please contact Amgen Medical Information on +44 (0) 1223 436441

Physicians who express an interest in initiating self-administration of Nplate (romiplostim) for specific patients are provided with a Home Administration Training pack for those patients. The HAT pack includes materials for HCPs on how to select and train patients for self-administration of romiplostim; and for patients, in order to help them with the process of preparation and self-administration of the correct dose of romiplostim. To request a copy of this material, please contact Amgen Medical Information on +44 (0) 1223 436441

Physicians who express an interest in initiating self-administration of Nplate (romiplostim) for specific patients are provided with a Home Administration Training pack for those patients. The HAT pack includes materials for HCPs on how to select and train patients for self-administration of romiplostim; and for patients, in order to help them with the process of preparation and self-administration of the correct dose of romiplostim. To request a copy of this material, please contact Amgen Medical Information on +44 (0) 1223 436441

Physicians who express an interest in initiating self-administration of Nplate (romiplostim) for specific patients are provided with a Home Administration Training pack for those patients. The HAT pack includes materials for HCPs on how to select and train patients for self-administration of romiplostim; and for patients, in order to help them with the process of preparation and self-administration of the correct dose of romiplostim. To request a copy of this material, please contact Amgen Medical Information on +44 (0) 1223 436441